article thumbnail

Biomechanical factors and atherosclerosis localization: insights and clinical applications

Frontiers in Cardiovascular Medicine

Although the entire vascular bed is constantly exposed to the same risk factors, atherosclerosis manifests a distinct intra-individual pattern in localization and progression within the arterial vascular bed.

article thumbnail

Naturally Occurring Atherosclerosis Progression and In-Stent Restenosis: Exploring Histomorphological Associations Using Optical Coherence Tomography

Journal of Cardiovascular Pharmacology

Abstract: The mechanism of in-stent restenosis (ISR) remains elusive, and in-stent neoatherosclerosis (ISNA) may hold siginificant pathophysiological implications. Nevertheless, the correlation between ISNA and the progression of untreated coronary segments affected by native atherosclerosis remains incompletely investigated.

Stents 40
article thumbnail

Abstract 188: Rescue Left Middle Cerebral Artery Stenting With Xience Skypoint Everolimus?Eluting Stent: Technical Report

Stroke: Vascular and Interventional Neurology

IntroductionDrug‐eluting stent (DES) use in symptomatic intracranial atherosclerosis disease (ICAD) has been described in the literature using different guiding and distal access catheters. Decision was made to deploy a drug eluting stent into the stenosed M1 segment.

Stents 40
article thumbnail

SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis

Frontiers in Cardiovascular Medicine

Coronary heart disease is a narrowing or obstruction of the vascular cavity caused by atherosclerosis of the coronary arteries, which leads to myocardial ischemia and hypoxia. At present, percutaneous coronary intervention (PCI) is an effective treatment for coronary atherosclerotic heart disease.

article thumbnail

Abstract 41: Territorial Stroke in SAMMPRIS: Critical Analyses of Stroke Prevention in Intracranial Atherosclerosis

Stroke Journal

Introduction:Current guidelines do not support the use of stenting for severe symptomatic intracranial atherosclerotic disease (ICAD) over maximal medical therapy (MMT) as first line treatment. Periprocedural stroke was defined as <7d from stent placement. Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025.

Stroke 40
article thumbnail

Abstract 132: Angioplasty and Stenting for Symptomatic Vertebral Artery Atherosclerotic Disease: A Systematic Review and Meta?Analysis

Stroke: Vascular and Interventional Neurology

IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).

article thumbnail

Contemporary Trends in Utilization of Rescue Intracranial Stenting During Mechanical Thrombectomy in Patients With Stroke in the United States

Stroke: Vascular and Interventional Neurology

BACKGROUNDRescue intracranial stenting (RICS) is increasingly recognized as a potentially effective rescue strategy following failed mechanical thrombectomy (MT) for large vessel occlusion due to intracranial atherosclerosis, but populationlevel data on contemporary patterns of RICS utilization in MT are lacking. had codes for MT.

Stents 40